Johan Malm
Johan Malm publishes mostly in Endocrinology, Diabetes and Metabolism, Genetics and Molecular Biology, on topics such as Thyroid Disorders and Treatments, Estrogen and related hormone effects and Growth Hormone and Insulin-like Growth Factors.
- World rank
- #3,482,521 of 7,710,434 ranked researchers
- Rank in Sweden
- #43,419 of 71,437
- Works
- 33
- Citations
- 1.2k
- Citations per work
- 36.6
What does Johan Malm research?
Johan Malm's work is mostly in Medicine (45%), Biochemistry, Genetics and Molecular Biology (27%), Chemistry (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1545.1%
- Medicine1545.1%
- Life Sciences1029.2%
- Everything else720.8%
- Physical Sciences24.9%
- Chemistry24.9%
- 1Endocrinology, Diabetes and Metabolism43% of their works
- 2Genetics13% of their works
- 3Molecular Biology13% of their works
- 4Organic Chemistry5% of their works
- 5Endocrine and Autonomic Systems2% of their works
- 6Oncology2% of their works
Research topics
- Thyroid Disorders and Treatments
- Estrogen and related hormone effects
- Growth Hormone and Insulin-like Growth Factors
- Hormonal Regulation and Hypertension
- Retinoids in leukemia and cellular processes
- Regulation of Appetite and Obesity
- Hormonal and reproductive studies
- Metal complexes synthesis and properties
Which keywords describe Johan Malm's research?
The keywords of their largest research topics: Cardiovascular Risk, Thyroid Dysfunction, Thyroid Hormone, Nuclear Receptors, Estrogen, Receptor, Metabolic Syndrome and IGF-1.
- Platinum-Based Drugs
- Hormone Therapy
- Cisplatin Resistance
- Acute Promyelocytic Leukemia
- Aldosterone
- IGF-1
- Receptor
- Nuclear Receptors
- Thyroid Dysfunction
- Cardiovascular Risk
- Thyroid Hormone
- Estrogen
- Metabolic Syndrome
- Insulin-like Growth Factors
- Primary Aldosteronism
- Retinoic Acid
- Ghrelin
- Leptin
- Testosterone
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Cardiovascular Risk202 topics
- Thyroid Dysfunction181 topic
- Thyroid Hormone181 topic
- Nuclear Receptors152 topics
- Estrogen101 topic
- Receptor101 topic
- Metabolic Syndrome92 topics
- IGF-181 topic
- Insulin-like Growth Factors81 topic
- Aldosterone71 topic
- Primary Aldosteronism71 topic
- Acute Promyelocytic Leukemia51 topic
- Retinoic Acid51 topic
- Cisplatin Resistance21 topic
- Ghrelin21 topic
- Hormone Therapy21 topic
- Leptin21 topic
- Platinum-Based Drugs21 topic
- Testosterone21 topic
Where does Johan Malm work?
Johan Malm's main affiliation in the publication record is Karo Pharma (Sweden), Sweden.
How many publications and citations does Johan Malm have?
OpenAlex counts 33 works and 1,207 citations for Johan Malm, an h-index of 16, ranking #3,482,521 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Johan Malm
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Johan Malm. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.